Data from a well-designed Swedish study indicate that green tea and Roiboos tea—but not black tea—can significantly inhibit Angiotensin Converting Enzyme, and potentially lower blood pressure. An HerbClip from the American Botanical Council.
Statistically, the prevalence of heart failure increases with age, but a new prospective study is validating what holistic physicians have known for years: that a healthy lifestyle can markedly reduce the risk.
A new study
shows that tocotrienols, an important component of naturally occurring Vitamin E, can prevent neural damage following ischemic stroke, potentially improving post-stroke outcomes.
Folic acid supplementation before and during pregnancy is widely recommended for preventing neural tube defects. New data indicate that it can also reduce the risk of cleft lip and congenital heart defects. At the other end of the age spectrum, folic acid in combination with vitamins B6 and B12 can reduce a woman’s risk of age-related macular degeneration.
Clinical research on CoQ10 continues to point toward new uses including blood pressure reduction, glycemic control and potentially reducing risk of neurodegenration. CoQ10 in its reduced form, known as ubiquinol, often improves outcomes in conditions like as severe heart failure, when the more common ubiquinone form, has proven ineffective.
Hibiscus, a popular tea herb in many parts of the world, can markedly lower systolic blood pressure in type II diabetic people with mild hypertension, according to a recent clinical trial. On the other hand, black tea tends to increase systolic pressure.
Chelation therapy to prevent heart attacks has never been accepted by mainstream cardiologists, but it is popular none the less, and increasingly so in the wake of trials questioning the value of drug-eluting stents. The Trial to Assess Chelation Therapy (TACT), a $30 million NIH-sponsored study, will hopefully provide definitive answers on whether chelation has a rightful place in heart disease prevention.
PHILADELPHIA—Holistic medicine is often considered more preventive than therapeutic, especially when it comes to cardiovascular disease. But even patients with advanced heart disease can benefit greatly from multimodal natural therapeutics.
Niacin is every effective in reducing LDL and elevating HDL or "good" cholesterol. But it is under-used in part because many people taking standard forms of niacin experience intense flushing. Extended release forms of niacin are now available that eliminate this problem. A statin-niacin combination called Advicor is "the ideal drug combination" for reducing heart disease risk, says cardiologist William Insull, MD.
ANAHEIM, CA—Statins will only go so far in reducing the incidence of cardiovascular events, said H. Robert Superko, MD, at Nutracon, an annual conference on advances in nutraceutical product development.